Clinical Trial Update: A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 study reporting pharmacokinetics and pharmacodynamics of IPX203 in patients with advanced Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• IPX203

Snippet

Sponsor: Impax Laboratories, LLC | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED